{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:13:52Z","timestamp":1782454432723,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502605"],"award-info":[{"award-number":["2022YFC2502605"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82170163"],"award-info":[{"award-number":["NSFC82170163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2017A030313601"],"award-info":[{"award-number":["No. 2017A030313601"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06576-8","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:52:27Z","timestamp":1766458347000},"page":"6339-6349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intensified pegylated-asparaginase in consolidation therapy improved outcome of allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Junjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"issue":"25","key":"6576_CR1","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV et al (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993). Blood 114(25):5136\u20135145","journal-title":"Blood"},{"issue":"4","key":"6576_CR2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"AH Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM et al (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the international ALL trial (MRC UKALL XII\/ECOG E2993). Blood 111(4):1827\u20131833","journal-title":"Blood"},{"issue":"6","key":"6576_CR3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E et al (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 27(6):911\u2013918","journal-title":"J Clin Oncol"},{"issue":"3","key":"6576_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2014.229","volume":"29","author":"DJ DeAngelo","year":"2015","unstructured":"DeAngelo DJ, Stevenson KE, Dahlberg SE et al (2015) Long-term outcome of a pediatric-inspired regimen used for adults aged 18\u201350 years with newly diagnosed acute lymphoblastic leukemia. Leukemia 29(3):526\u2013534","journal-title":"Leukemia"},{"issue":"10","key":"6576_CR5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.25229","volume":"93","author":"SE Siegel","year":"2018","unstructured":"Siegel SE, Advani A, Seibel N et al (2018) Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens. Am J Hematol 93(10):1254\u20131266","journal-title":"Am J Hematol"},{"issue":"14","key":"6576_CR6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","volume":"133","author":"W Stock","year":"2019","unstructured":"Stock W, Luger SM, Advani AS et al (2019) A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood 133(14):1548\u20131559","journal-title":"Blood"},{"issue":"9","key":"6576_CR7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood-2016-07-692608","volume":"129","author":"DI Marks","year":"2017","unstructured":"Marks DI, Rowntree C (2017) Management of adults with T-cell lymphoblastic leukemia. Blood 129(9):1134\u20131142","journal-title":"Blood"},{"issue":"3","key":"6576_CR8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon MD, Shuster J, Pullen J et al (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a pediatric oncology group study. Leukemia 13(3):335\u2013342","journal-title":"Leukemia"},{"issue":"17","key":"6576_CR9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","volume":"38","author":"S Gupta","year":"2020","unstructured":"Gupta S, Wang C, Raetz EA et al (2020) Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: A report from the children\u2019s oncology group. J Clin Oncol 38(17):1897\u20131905","journal-title":"J Clin Oncol"},{"issue":"5","key":"6576_CR10","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2007-02-070342","volume":"111","author":"NL Seibel","year":"2008","unstructured":"Seibel NL, Steinherz PG, Sather HN et al (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the children\u2019s oncology group. Blood 111(5):2548\u20132555","journal-title":"Blood"},{"issue":"3","key":"6576_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O\u2019Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18(3):547\u2013561","journal-title":"J Clin Oncol"},{"issue":"2","key":"6576_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/bjh.19467","volume":"205","author":"X Xu","year":"2024","unstructured":"Xu X, Huang Z, Ding C et al (2024) STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B-cell acute lymphoblastic leukaemia. Br J Haematol 205(2):517\u2013528. https:\/\/doi.org\/10.1111\/bjh.19467","journal-title":"Br J Haematol"},{"issue":"12","key":"6576_CR13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41409-022-01797-1","volume":"57","author":"B Tang","year":"2022","unstructured":"Tang B, Cai Z, Wang Z et al (2022) Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia. Bone Marrow Transpl 57(12):1751\u20131757","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"6576_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.22.00767","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang H, Fan Z, Huang F et al (2023) Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: an Open-Label, multicenter, phase III trial. J Clin Oncol 41(2):343\u2013353","journal-title":"J Clin Oncol"},{"issue":"2","key":"6576_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjh.19223","volume":"204","author":"Z Wang","year":"2023","unstructured":"Wang Z, Fan Z, Wu Z et al (2023) PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic Haematopoietic stem cell transplantation. Br J Haematol 204(2):628\u2013637. https:\/\/doi.org\/10.1111\/bjh.19223","journal-title":"Br J Haematol"},{"issue":"5","key":"6576_CR16","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1002\/hem3.82","volume":"8","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zhang L, Gong X et al (2024) An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia. Hemasphere 8(5):e82","journal-title":"Hemasphere"},{"issue":"11","key":"6576_CR17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41409-022-01796-2","volume":"57","author":"HZ Qi","year":"2022","unstructured":"Qi HZ, Xu J, Yang QQ et al (2022) Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission. Bone Marrow Transpl 57(11):1704\u20131711","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"6576_CR18","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.3324\/haematol.2024.285590","volume":"109","author":"J Chen","year":"2024","unstructured":"Chen J, Cai Z, Huang Z et al (2024) Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort. Haematologica 109(12):4125\u20134130. https:\/\/doi.org\/10.3324\/haematol.2024.285590","journal-title":"Haematologica"},{"issue":"9","key":"6576_CR19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","volume":"26","author":"T Kalina","year":"2012","unstructured":"Kalina T, Flores-Montero J, van der Velden VH et al (2012) EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 26(9):1986\u20132010","journal-title":"Leukemia"},{"issue":"1","key":"6576_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-00859-5","volume":"13","author":"S Yu","year":"2020","unstructured":"Yu S, Huang F, Fan Z et al (2020) Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data. J Hematol Oncol 13(1):18","journal-title":"J Hematol Oncol"},{"issue":"7","key":"6576_CR21","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41375-020-01090-4","volume":"35","author":"H Liu","year":"2021","unstructured":"Liu H, Xuan L, Lin R et al (2021) A new pre-emptive TKIs strategy for preventing relapse based on BCR\/ABL monitoring for Ph\u2009+\u2009ALL undergoing allo-HCT: a prospective clinical cohort study. Leukemia 35(7):2054\u20132063","journal-title":"Leukemia"},{"issue":"9","key":"6576_CR22","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(20)30455-1","volume":"21","author":"L Xuan","year":"2020","unstructured":"Xuan L, Wang Y, Huang F et al (2020) Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic Haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial. Lancet Oncol 21(9):1201\u20131212","journal-title":"Lancet Oncol"},{"issue":"2","key":"6576_CR23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3324\/haematol.2013.094193","volume":"99","author":"DI Marks","year":"2014","unstructured":"Marks DI, Woo KA, Zhong X et al (2014) Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica 99(2):322\u2013328","journal-title":"Haematologica"},{"issue":"5","key":"6576_CR24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbmt.2020.01.003","volume":"26","author":"A Bazarbachi","year":"2020","unstructured":"Bazarbachi A, Labopin M, Angelucci E et al (2020) Haploidentical transplantation with Post-Transplantation cyclophosphamide for T cell acute lymphoblastic leukemia: A report from the European society for blood and marrow transplantation acute leukemia working party. Biol Blood Marrow Transpl 26(5):936\u2013942","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"6576_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/ejh.13178","volume":"102","author":"P Barba","year":"2019","unstructured":"Barba P, Morgades M, Montesinos P et al (2019) Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials. Eur J Haematol 102(1):79\u201386","journal-title":"Eur J Haematol"},{"issue":"7","key":"6576_CR26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","volume":"126","author":"MR Litzow","year":"2015","unstructured":"Litzow MR, Ferrando AA (2015) How I treat T-cell acute lymphoblastic leukemia in adults. Blood 126(7):833\u2013841","journal-title":"Blood"},{"issue":"23","key":"6576_CR27","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V126.23.3762.3762","volume":"126","author":"VK Kota","year":"2015","unstructured":"Kota VK, Hathaway AR, Shah BD et al (2015) Poor outcomes with hyper CVAD induction for T-Cell lymphoblastic leukemia\/lymphoma. BloodBlood 126(23):3762","journal-title":"BloodBlood"},{"issue":"10","key":"6576_CR28","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","volume":"109","author":"M Wetzler","year":"2007","unstructured":"Wetzler M, Sanford BL, Kurtzberg J et al (2007) Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: cancer and leukemia group B study 9511. Blood 109(10):4164\u20134167","journal-title":"Blood"},{"issue":"1","key":"6576_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/leu.2016.219","volume":"31","author":"B Patel","year":"2017","unstructured":"Patel B, Kirkwood AA, Dey A et al (2017) Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia 31(1):58\u201364","journal-title":"Leukemia"},{"key":"6576_CR30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2021.08.025","volume":"157","author":"LJ Brigitha","year":"2021","unstructured":"Brigitha LJ, Pieters R, van der Sluis IM (2021) How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review. Eur J Cancer 157:238\u2013249","journal-title":"Eur J Cancer"},{"issue":"28","key":"6576_CR31","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","volume":"23","author":"A Pession","year":"2005","unstructured":"Pession A, Valsecchi MG, Masera G et al (2005) Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol 23(28):7161\u20137167","journal-title":"J Clin Oncol"},{"issue":"4","key":"6576_CR32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2015.64.8907","volume":"34","author":"R Bassan","year":"2016","unstructured":"Bassan R (2016) Using minimal residual disease to improve treatment response definitions and hematopoietic cell transplantation strategy in acute leukemia. J Clin Oncol 34(4):300\u2013302","journal-title":"J Clin Oncol"},{"issue":"1","key":"6576_CR33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/bmt.2016.194","volume":"52","author":"JE Brammer","year":"2017","unstructured":"Brammer JE, Saliba RM, Jorgensen JL et al (2017) Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Bone Marrow Transpl 52(1):20\u201327","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"6576_CR34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjh.12639","volume":"164","author":"A Balduzzi","year":"2014","unstructured":"Balduzzi A, Di Maio L, Silvestri D et al (2014) Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? Br J Haematol 164(3):396\u2013408","journal-title":"Br J Haematol"},{"issue":"6","key":"6576_CR35","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/leu.2011.351","volume":"26","author":"A Spyridonidis","year":"2012","unstructured":"Spyridonidis A, Labopin M, Schmid C et al (2012) Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the acute leukemia working party of EBMT. Leukemia 26(6):1211\u20131217","journal-title":"Leukemia"},{"issue":"6","key":"6576_CR36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ajh.26160","volume":"96","author":"S Liu","year":"2021","unstructured":"Liu S, Deng B, Yin Z et al (2021) Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation. Am J Hematol 96(6):671\u2013679","journal-title":"Am J Hematol"},{"issue":"2","key":"6576_CR37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","volume":"32","author":"YJ Chang","year":"2012","unstructured":"Chang YJ, Zhao XY, Huo MR et al (2012) Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation. J Clin Immunol 32(2):268\u2013280","journal-title":"J Clin Immunol"},{"issue":"18","key":"6576_CR38","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","volume":"125","author":"A Roberto","year":"2015","unstructured":"Roberto A, Castagna L, Zanon V et al (2015) Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. Blood 125(18):2855\u20132864","journal-title":"Blood"},{"issue":"2","key":"6576_CR39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/bmt.2014.266","volume":"50","author":"A Roberto","year":"2015","unstructured":"Roberto A, Castagna L, Gandolfi S et al (2015) B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY. Bone Marrow Transpl 50(2):317\u2013319","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"6576_CR40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.2022017003","volume":"141","author":"M Svaton","year":"2023","unstructured":"Svaton M, Skotnicova A, Reznickova L et al (2023) NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol. Blood 141(5):529\u2013533","journal-title":"Blood"},{"issue":"8","key":"6576_CR41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ajh.24419","volume":"91","author":"ME Rytting","year":"2016","unstructured":"Rytting ME, Jabbour EJ, Jorgensen JL et al (2016) Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-M\u00fcnster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen. Am J Hematol 91(8):819\u2013823","journal-title":"Am J Hematol"},{"issue":"8","key":"6576_CR42","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3324\/haematol.2020.251686","volume":"106","author":"MB Geyer","year":"2021","unstructured":"Geyer MB, Ritchie EK, Rao AV et al (2021) Pediatric-inspired chemotherapy incorporating Pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia. Haematologica 106(8):2086\u20132094","journal-title":"Haematologica"},{"issue":"18","key":"6576_CR43","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/bloodadvances.2023009754","volume":"7","author":"J Rangel-Pati\u00f1o","year":"2023","unstructured":"Rangel-Pati\u00f1o J, Lee-Tsai YL, Urbalejo-Ceniceros VI et al (2023) A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in central America. Blood Adv 7(18):5202\u20135209","journal-title":"Blood Adv"},{"issue":"2","key":"6576_CR44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/bloodadvances.2020002439","volume":"5","author":"AS Advani","year":"2021","unstructured":"Advani AS, Larsen E, Laumann K et al (2021) Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Adv 5(2):504\u2013512","journal-title":"Blood Adv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06576-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:15:13Z","timestamp":1767485713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06576-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6576"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06576-8","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}